Thus, they identified mutations in MYCN, PTPN14, and LATS1. MYCN alterations were observed in 30% of the studied BCC samples, most of them being identified in the Myc box 1 (MB1) region. The gene discussed is MYCN; the disease is skin basal cell carcinoma.